Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 560 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
Filed	Form	What it is	Accession number
2022-08-0416:08 ET	10-Q	Quarterly reportPeriod 2022-06-30	0001447028-22-000047
2022-08-0407:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-22-005343
2022-07-2016:12 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-004906
2022-06-2709:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-004546
2022-06-0806:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-004212
2022-06-0607:31 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-004157
2022-05-3116:05 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001447028-22-000041
2022-05-2617:06 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-003988
2022-05-2407:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-003897
2022-05-0516:06 ET	10-Q	Quarterly reportPeriod 2022-03-31	0001447028-22-000025
2022-05-0507:31 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-003268
2022-04-1116:05 ET	DEF 14A	Proxy statementPeriod 2022-05-25	0001140361-22-013967
2022-03-0317:22 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-22-030110
2022-03-0316:43 ET	10-K	Annual reportPeriod 2021-12-31	0001447028-22-000019
2022-03-0307:32 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-001596
2022-02-2806:15 ET	8-K	8.01 Other events	0001171843-22-001419
2022-01-2407:31 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-22-000411
2021-12-1407:31 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-008510
2021-12-1307:38 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-008473
2021-12-1007:30 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001447028-21-000072
2021-12-0707:31 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-008357
2021-12-0112:50 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-008240
2021-11-1207:30 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001171843-21-007863
2021-11-1206:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-007826
2021-11-0416:07 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001447028-21-000059
2021-11-0407:31 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-007507
2021-10-0816:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001104659-21-124592
2021-08-0516:13 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001447028-21-000052
2021-08-0507:31 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-005530
2021-07-1407:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-004859
2021-07-0707:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-004761
2021-07-0607:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-004704
2021-06-2907:02 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-004577
2021-06-2808:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-004544
2021-06-0116:03 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001447028-21-000032
2021-05-0516:29 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001447028-21-000027
2021-05-0507:32 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-003133
2021-04-0814:52 ET	DEF 14A	Proxy statementPeriod 2021-05-26	0001104659-21-047991
2021-04-0107:32 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-002226
2021-03-1607:32 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-001812
2021-03-0417:12 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001104659-21-032191
2021-03-0416:32 ET	10-K	Annual reportPeriod 2020-12-31	0001447028-21-000021
2021-03-0407:32 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-21-001522
2021-02-2607:32 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-001364
2021-02-0107:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-000629
2021-01-2507:32 ET	8-K	2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-21-000432
2020-12-1007:32 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-20-008493
2020-11-1608:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-20-008007
2020-11-0516:11 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001447028-20-000150
2020-11-0508:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-20-007636

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.